Kenvue (MEX:KVUE) EBIT per Share : MXN17.86 (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Kenvue EBIT per Share?

Kenvue's EBIT per Share for the three months ended in Sep. 2024 was MXN6.89. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was MXN17.86.

During the past 12 months, the average EBIT per Share Growth Rate of Kenvue was -3.90% per year. During the past 3 years, the average EBIT per Share Growth Rate was -4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Kenvue's EBIT per Share or its related term are showing as below:

MEX:KVUE' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -4.8 Med: -0.55 Max: 3.7
Current: -4.8

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Kenvue was 3.70% per year. The lowest was -4.80% per year. And the median was -0.55% per year.

MEX:KVUE's 3-Year EBIT Growth Rate is ranked worse than
66.16% of 1504 companies
in the Consumer Packaged Goods industry
Industry Median: 5.35 vs MEX:KVUE: -4.80

Kenvue's EBIT for the three months ended in Sep. 2024 was MXN13,252 Mil.

Kenvue EBIT per Share Historical Data

The historical data trend for Kenvue's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue EBIT per Share Chart

Kenvue Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

23.95

31.47

31.77

27.22

23.37

Kenvue Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial										6.22	4.96	4.51	1.50	6.89

Kenvue EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Kenvue's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	43250.384	/	1850.325
=	23.37

Kenvue's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	13251.572	/	1924.000
=	6.89

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN17.86

Kenvue (MEX:KVUE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Kenvue EBIT per Share Related Terms

Thank you for viewing the detailed overview of Kenvue's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Kenvue Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (MEX:KVUE) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

KVUE:USA J4D:Germany

Address

199 Grandview Road, Skillman, NJ, USA, 08558

Website

https://www.kenvue.com

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.